Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis

Authors

  • J. Maloney, MD,

    1. Cherry Creek Dermatology,Denver, Colorado, Private Practice, Rutherford, New Jersey, Midwest Cutaneous Research Corp., Clinton Township, Michigan, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, Glaxo Dermatology, Research Triangle Park, North Carolina
    Search for more papers by this author
  • Manuel Morman, PhD, MD,

    1. Cherry Creek Dermatology,Denver, Colorado, Private Practice, Rutherford, New Jersey, Midwest Cutaneous Research Corp., Clinton Township, Michigan, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, Glaxo Dermatology, Research Triangle Park, North Carolina
    Search for more papers by this author
  • Daniel Stewart, DO,

    1. Cherry Creek Dermatology,Denver, Colorado, Private Practice, Rutherford, New Jersey, Midwest Cutaneous Research Corp., Clinton Township, Michigan, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, Glaxo Dermatology, Research Triangle Park, North Carolina
    Search for more papers by this author
  • Michael Tharp, MD,

    1. Cherry Creek Dermatology,Denver, Colorado, Private Practice, Rutherford, New Jersey, Midwest Cutaneous Research Corp., Clinton Township, Michigan, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, Glaxo Dermatology, Research Triangle Park, North Carolina
    Search for more papers by this author
  • Rukmini Rajagopalan, DrPH, MBA, RN

    1. Cherry Creek Dermatology,Denver, Colorado, Private Practice, Rutherford, New Jersey, Midwest Cutaneous Research Corp., Clinton Township, Michigan, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, Glaxo Dermatology, Research Triangle Park, North Carolina
    Search for more papers by this author

Jeanine Johnson Brown PharmD Glaxo Dermatology, A Division of Glaxo Wellcome Inc., Five Moore Drive, Research Triangle Park, NC 27709

No abstract is available for this article.

Ancillary